A LETTER FROM THE EXECUTIVE DIRECTOR REPORT ON NANP S CONTINUING PARTICIPATION IN CORAR MEETINGS INCREASING JCAHO INFLUENCE ON NUCLEAR PHARMACY?
|
|
- Norah Clarke
- 6 years ago
- Views:
Transcription
1 N a t i o n a l A s s o c i a t i o n o f N u c l e a r P h a r m a c i e s N E W S L E T T E R SPRING 2006 INSIDE THIS ISSUE : A LETTER FROM THE EXECUTIVE DIRECTOR REPORT ON NANP S CONTINUING PARTICIPATION IN CORAR MEETINGS INCREASING JCAHO INFLUENCE ON NUCLEAR PHARMACY? NRC PETITIONED TO PARTIALLY RESCIND PATIENT RELEASE RULE USP CHAPTER <797> UPDATE INDUSTRY PRESENTERS AT THE UPCOMING NANP GENERAL BUSINESS MEETING
2 Page 2 A LETTER FROM THE EXECUTIVE DIRECTOR To NANP members and fellow nuclear pharmacists, I am writing on behalf of the NANP Board of Directors to update you on our activities since March of 2005, and to invite you to the NANP General Business Meeting. I am pleased to report that NANP is healthy and actively working on behalf of over 450 nuclear pharmacies in the US. As of this writing, there are currently 323 NANP members including large chains and independents, academics/hospital-based, as well as both PET and traditional nuclear pharmacies. The support of Cardinal Health NPS, Tyco/Mallinckrodt, GE Healthcare, PETNet, as well as over 35 independent and institutional members allows us to continue NANP activities in three areas: 1) regulatory and government affairs, 2) professional education to promote the best business practices in nuclear pharmacy, and 3) interaction with commercial manufacturers to bring you information regarding new products and services. We are pleased to welcome several new NANP members, including independent pharmacies and institutions, IBA/Eastern Isotopes (17 pharmacies) and two Associate Members- Molecular Insight Pharmaceuticals and International Isotopes Inc.- to our membership in Over the last year, we have participated in several regulatory and rule-making initiatives and monitored other issues. Chris Ondeck and I continue to participate in the Council on Radionuclides and Radiopharmaceuticals (CORAR) meetings representing NANP. The CORAR has reorganized their Manufacturing and Quality Standards, and Transportation Committees, and established the Nuclear Pharmacy Committee (NPC) to specifically address radiopharmaceutical distributors and manufacturers issues related to nuclear pharmacy. I am a non-voting member of the NPC representing NANP. This relationship with CORAR, and their manufacturer members, has allowed NANP to provide input directly to the manufacturers and regulators from the perspective of nuclear pharmacies. This interaction with CORAR is a tremendous opportunity for NANP to leverage our relatively small budget and organization to influence regulatory and government affairs on behalf of our member nuclear pharmacies. Discussions are ongoing to refine the NANP strategic plan and to increase our effectiveness in representing the unique needs of nuclear pharmacies and bring value to our members. The NANP is working to maintain our regulatory and government affairs activities at the national level, and to increase our activities at the state and regional levels. The NANP is continuing to develop our interactions with distributors and manufacturers to bring them into our organization as Associate Members to support our activities. We are also working to improve communications among NANP members. Plans are underway to bring enhanced utility to the NANP website in order to improve member access to timely information and to maintain links to useful materials. We continue to work closely with the APhA and Society of Nuclear Medicine to identify and support their efforts that may impact nuclear pharmacies and to ensure the consistency of their message to others regarding our business. The NANP was established in 1984 as a trade association representing nuclear pharmacies and maintains its unique place within the various professional organizations with which we often collaborate. Over the last 22 years, NANP has worked effectively to influence regulatory and legislative actions, to promote the business of nuclear pharmacies, and to educate commercial distributors and manufacturers of radiopharmaceuticals and radionuclides regarding the needs of nuclear pharmacies. Since our incep-
3 Page 3 tion in 1984, dues have remained $100 per pharmacy. At this time, some adjustment to correct for 20 years of inflation is necessary. The Board of Directors is now considering an increase in the annual dues in order to increase our level of activities at both local and national levels to achieve our objectives. I anticipate that NANP membership will continue to grow following enhancement of our member relations, timely communications, and the higher profile of our activities. Below is a partial list of issues on which NANP has taken action on behalf of our member nuclear pharmacies since March 2005: Monitoring and comment on the USP Sterile Compounding Committee continued activities related to USP <797>. Participation in the NRC stakeholders meeting on rulemaking to establish a regulatory framework for the expanded definition of byproduct material established by the Energy Policy Act of 2005 to discourage expansion of NRC Regulation of Naturally Occurring and Accelerator Produced Radioactive Materials or NARM. Letters to Congress and meetings with Rep. Wilson to remove the sunset clause from the Energy Bill that would have disallowed the export of highly-enriched uranium necessary for 99Molybdenum production by MDS Nordion. Letters to Congress in support of restoring funds earmarked for nucelar medicine research to the DOE budget. Participation in the Society of Nuclear Medicine activities: cgmp Working Group; Coding and Reimbursement Working Group, Committee on Radiopharmaceuticals, Committee on Pharmacopeia, and the Radiopharmaceutical Sciences Council. Continued interaction with APhA Section on Nuclear Pharmacy committees and leadership The NANP General Business Meeting and New Products/Regulatory Update will be held in conjunction with the APhA Annual Meeting, 9-11AM on Saturday, March 18 at Moscone-West Convention Center, Room I am very excited about our program and the opportunity to update you on NANP activities over the last year. We will hear presentations on new products by representatives from Molecular Insight, International Isotopes, and MDS Nordion. The results of the National Institutes of Standards and Technologies (NIST) Radiopharmaceutical Measurement Quality Program 90Y intercomparison test conducted in collaboration with NANP, will also be reported. This is a forum for NANP members to communicate with one another to identify priorities for the next year. I look forward to seeing you at the NANP and APhA meetings and to learning more about what NANP can do to benefit you, our members. Thank you for your continued support and for the opportunity to serve the NANP. Best wishes for safe travels. Jeff Norenberg Executive Director and Chairman
4 Page 4 REPORT ON NANP S CONTINUING PARTICIPATION IN CORAR MEETINGS By Chris Ondeck, Legal Counsel for NANP Partner, Crowell & Moring LLP This past year, NANP continued its relationship with the Council on Radionuclides and Radiopharmaceuticals (CORAR), to work on common interests in nuclear pharmacy issues. In particular, Chris Ondeck attended the December 7, 2006 CORAR meetings as NANP s counsel and representative. The summary of issues addressed at those meetings, and their relevance to NANP, follows. CORAR s Committee of Manufacturing, Quality and Standards discussed several issues relevant to NANP: (a) the OSHA request for information on Ionizing Radiation CORAR submitted a response, and OSHA needs to update its antiquated standard; (b) NRC regulation of NARM CORAR questioned the OSHA representative (Scott Moore) as to what materials produced in an accelerator is considered to be NARM, and the response was that everything made radioactive, including targets and activated materials could be considered NARM the current status is that OSHA is in the drafting stage and is not requesting input currently; and (c) NRC Extremity Dose Monitoring CORAR has requested NANP input and assistance in creating a draft guidance document the NRC rulemaking could have significant impact on NANP members. CORAR s Committee of Nuclear Pharmacy similarly discussed issues relevant to NANP: (a) Revisions to USP Chapter 797 CORAR has submitted comments on the revisions, and the comments were shared with Jeff Norenberg; (b) FDA PET Rulemaking PETNET has submitted comments; and (c) discussion of mission and role of this CORAR committee whether the Committee should be continued was discussed, and the agreement was to recommend to CORAR that the Committee continue for at least one more year if the Committee is discontinued, NANP may need to assume additional industry advocacy. INCREASING JCAHO INFLUENCE ON NUCLEAR PHARMACY? By Richard A. Nickel, MS, RPh Mallinckrodt Inc. The Joint Commission for Accreditation of Healthcare Organizations is the principle accreditation body for customers of commercial nuclear pharmacies. Presently, the Commission has no accreditation pathway for nuclear pharmacies, but they do influence the nuclear pharmacy community. When preparing for an upcoming survey, Directors of Pharmacy may request information on USP Chapter <797> compliance with all outsourced sterile compounding, including radiopharmaceuticals. In addition, the Medication Management (MM) Standard which requires a pharmacist to review all medication orders is interpreted by the Commission to apply to contract nuclear pharmacies. NRC PETITIONED TO PARTIALLY RESCIND PATIENT RELEASE RULE by James A. Ponto, MS, RPh, BCNP Chief Nuclear Pharmacist and Professor (Clinical) University of Iowa Hospitals and Clinics An individual recently petitioned the NRC to rescind its patient release rule which allows patients treated with more than 30 mci I-131 to be released
5 Page 5 based on calculations that each member of the general public will receive no more than 500 mrem from the patient. The NRC received the petition for rulemaking submitted by Peter G. Crane (petitioner) entitled Re: Petition for Partial Revocation of the Patient Release Criteria Rule. The petitioner is an attorney who was formerly employed in the NRC s Office of the General Counsel from 1975 until his retirement from the NRC in The petitioner requests that the NRC partially revoke 10 CFR 35.75, Release of Individuals Containing Radiopharmaceuticals or Permanent Implants (Patient Release Criteria Rule). The petitioner believes the Patient Release Criteria Rule is defective on both legal and policy grounds. The petitioner recommends that 10 CFR be amended to prohibit the release of patients from radioactive isolation with more than the equivalent of 30 millicuries of radioactive iodine-131 in their systems. The NRC is soliciting public comment on the petition for rulemaking. For more information, see the Federal Register notice: crane_lib/ htm and the petition: downloader/crane_lib/ pdf Comments regarding the petition must be submitted by March 6, Although the proposed revision to 10 CFR expressed in the petition does not directly affect nuclear pharmacy practice, it does affect many of our nuclear medicine colleagues and customers. Accordingly, the NANP, as on organization, and several NANP members, individually, have submitted comments to the NRC urging denial of the petition. Some of the points discussed in these comments included: release of patients containing 30 mci is permitted only when calculations demonstrate acceptable exposure to members of the public AND the patient is willing and able to comply with radiation protection instructions; thus, release is allowed for most patients, but some patients still require hospitalization; the limit of 500 mrem for radiation exposure to members of the public is consistent with NCRP recommendations for infrequent exposure, and doses at this level are not considered hazardous; compliance with the current release rule requires that the patient be given written instructions; thus, the patient has this information readily available in case of confusion or forgetfulness; the guidance for current release rule incorporates conservative assumptions and calculations; several published articles and unpublished experience all demonstrate that actual exposures to family members, as determined by having them wear dosimeters, is substantially lower than anticipated exposures based on release calculations. Purported instances of excessive exposure to others are generally the result of non-compliance with the current release rule and associated guidance, rather than a problem with the rule itself; and ALARA, as defined in 10 CFR 20, includes the economics of improvements in relation to benefits to the public health and safety, and other societal and socioeconomic considerations, and in relation to utilization of nuclear energy and licensed materials in the public interest. The current release rule is beneficial in minimizing hospitalization costs and is generally in the best interests of the patients and their family members.
6 Page 6 In summary, a large body of evidence exists supporting the reasonableness, appropriateness, and positive value of the current release rule. USP CHAPTER <797> UPDATE By Richard A. Nickel, MS, RPh Mallinckrodt Inc. Pharmacy Compounding-Sterile Preparations (USP Chapter <797>) became official on January 1, 2004 and has not yet been revised. Since that time, USP has received comments from a variety of sources and it is expected that the proposed revision will be in the next Pharmacopeial Forum. State Board of Pharmacy response has been very uneven, varying from virtually complete adoption to no response at all. Many states are considering revising their rules to adopt or acknowledge the Chapter, but may be waiting for the next revision. The National Association of Boards of Pharmacy may be introducing their newly revised Model Rules at their upcoming April meeting. It is expected that the new Model Rules, if introduced, will adopt the recommendations of their Task Force on Standards for Compounding. If they do, the pace of activity by each State Board may increase in this area. INDUSTRY PRESENTERS AT THE UPCOMING NANP GENERAL BUSINESS MEETING Wendy Graham-Coco, Molecular Insight Pharmaceuticals, Inc. Zemiva (Iodofiltic acid I 123): Rapid assessment of low to intermediate risk chest pain patients with possible acute coronary syndrome (myocardial infarction or unstable angina) is an important diagnostic challenge. Over 3 million chest pain patients are hospitalized each year however, only 15% of these patients are ultimately diagnosed with ACS. A rapid and accurate assessment for ACS could potentially decrease unnecessary hospitalizations while improving chest pain triage. Zemiva (Iodofiltic acid I 123) is a radiolabeled fatty acid analog that is currently in Ph 2 clinical investigation for localization of myocardial ischemia utilizing SPECT imaging technology up to 30 hours after the ischemic event. SPECT imaging with Zemiva can be completed within 45 minutes of injection and does not require a stress test. Wendy s presentation will focus on the key properties of Zemiva including basic chemistry, pharmacology, dosing, handling and early clinical studies. Steve Laflin, International Isotopes Inc. International Isotopes Inc. (INIS) is a ten year old company that supplies iodine-131 radiochemical and manufactures a wide range of reference and calibration standards for nuclear pharmacy (flood source, dose calibrators, rod sources etc.). INIS imports its iodine-131 from South Africa and then custom packages and dispenses quantities tailored to pharmacy orders. INIS has demonstrated the quality and reliability of its products through thousands of shipments over the past several years. The presentation will be made by Steve T. Laflin the President and CEO of the company. Steve has been the President and CEO of International Isotopes Inc. since 2001 and involved in the nuclear industry in various radiological engineering positions for over 25 years beginning with the U.S. nuclear Navy and including commercial nuclear and government nuclear laboratory experience. He has a Bachelors degree in Health Physics from Idaho State University and is a Director for the Council on Radionuclides and Radiopharmaceuticals (CORAR).
7 Page 7 Colyn Steeves, MDS Nordion Inc. I-123 The Future is Now: Colyn will focus on the growth of I-123 usage by the pharmacy segment in the US as well as the growth of I-123 labeled radiopharmaceuticals. He will address actions that MDS Nordion has taken to reliably supply I-123 to nuclear pharmacies in the United States. N A T I O N A L A S S O C I A T I O N O F N U C L E A R P H A R M A C I E S O F F I C E R S Executive Director and Chairman Jeff Norenberg University of New Mexico Secretary/Treasurer Jerry Costanzo Cardinal Health NPS Legal Counsel Chris Ondeck B O A R D O F D I R E C T O R S Jerry Costanzo Cardinal Health NPS Rich DeVeau GE Medical Systems Rich Nickel Mallinckrodt DIS Michael Mosley PETNet Pharmaceuticals Danny R. Allen Independent NuTech Timothy M. Quinton Independent Radiopharmacy Inc James Ponto Institutional/Academic University of Iowa
8 N A T I O N A L A S S O C I A T I O N O F N U C L E A R P H A R M A C I E S Visit us online at for more information
DRAFT REGULATORY GUIDE
U.S. NUCLEAR REGULATORY COMMISSION August 2010 OFFICE OF NUCLEAR REGULATORY RESEARCH Division 8 DRAFT REGULATORY GUIDE Contact: H. Karagiannis (301) 251-7477 DRAFT REGULATORY GUIDE DG-8035 (Proposed Revision
More informationRadiopharmaceutical. Qualification. Checklist
Radiopharmaceutical Vendor Qualification Checklist section 1: RegulatoRy compliance Overview Nuclear pharmacies play an essential role in the preparation and distribution of radiopharmaceuticals for use
More informationOrganizations in Nuclear Medicine Part IV- Others of Importance. Bennett S. Greenspan, MD SNM MWM Orlando, FL January 27, 2012
Organizations in Nuclear Medicine Part IV- Others of Importance Bennett S. Greenspan, MD SNM MWM Orlando, FL January 27, 2012 Organizations in NM What Are They? What Do They Do? Why Should I Care? How
More informationHEALTH P H Y S I C S SOCIETY
HEALTH P H Y S I C S SOCIETY Specialists in Radiation Safety June 13, 2017 Cindy Bladey Office of Administration U.S. Nuclear Regulatory Commission Mail Stop: OWFN 12 H08 Washington, DC20555 0001 Eric
More information105 CMR: DEPARTMENT OF PUBLIC HEALTH
120.440: continued (1) If commercial software is used to generate shielding requirements, also identify the software used and the version/ revision date. (2) If the software used to generate shielding
More informationDose estimation of the radiation workers in the Cyclotron and. PET/CT center
Dose estimation of the radiation workers in the Cyclotron and PET/CT center Wei Zhang, Xirong Yu, Ke Yang, Shixue Li Wei Zhang, M.M., PhD (c), School of Public Health, Shandong University/Department of
More informationRADIATION SAFETY COMMITTEE
RADIATION SAFETY COMMITTEE PURPOSE This procedure defines the membership, authority, responsibilities and operating rules of the University's Radiation Safety Committee. POLICY The Radiation Safety Committee
More informationNUCLEAR MEDICINE RESIDENT DUTIES
NUCLEAR MEDICINE RESIDENT DUTIES General The American Board of Radiology requires four months training in Nuclear Medicine. Residents will be assigned at least 4 rotations on service. Rotations will be
More informationAAPM Responds to Follow up Questions from Congress after Hearing on Radiation in Medicine
AAPM Responds to Follow up Questions from Congress after Hearing on Radiation in Medicine Table of Contents Letter from the Congressman Henry A. Waxman, Chairman of the House of Representatives Committee
More informationNRC INFORMATION NOTICE 91-71: TRAINING AND SUPERVISION OF INDIVIDUALS SUPERVISED BY AN AUTHORIZED USER
Page 1 of 5 UNITED STATES NUCLEAR REGULATORY COMMISSION OFFICE OF NUCLEAR MATERIALS SAFETY AND SAFEGUARDS WASHINGTON, D.C. 20555 NRC INFORMATION NOTICE 91-71: TRAINING AND SUPERVISION OF INDIVIDUALS SUPERVISED
More informationCh. 129 NUCLEAR MEDICINE SERVICES CHAPTER 129. NUCLEAR MEDICINE SERVICES GENERAL PROVISIONS
Ch. 129 NUCLEAR MEDICINE SERVICES 28 129.1 CHAPTER 129. NUCLEAR MEDICINE SERVICES GENERAL PROVISIONS Sec. 129.1. Principle. 129.2. Organizational options. 129.3. Organization and staffing. 129.4. Director.
More informationCOMPLIANCE WITH THIS PUBLICATION IS MANDATORY
BY ORDER OF THE SECRETARY OF THE AIR FORCE AIR FORCE POLICY DIRECTIVE 40-2 12 JANUARY 2015 Aerospace Medicine RADIOACTIVE MATERIALS (NON-NUCLEAR WEAPONS) COMPLIANCE WITH THIS PUBLICATION IS MANDATORY ACCESSIBILITY:
More informationMandatory Licensure for Radiologic Personnel. Christopher Jason Tien
Mandatory Licensure for Radiologic Personnel Christopher Jason Tien Licensure Permission to perform a given occupation 3 rd party examinations State hands out licenses Occupations licensed: teachers, architects,
More informationThe Alphabet Soup of Regulatory Compliance: Being Prepared for Inspections. Objectives. Inspections are often unannounced, so DOCUMENTATION
The Alphabet Soup of Regulatory Compliance: Being Prepared for Inspections Linda Kroger, MS UC Davis Health System Objectives Recognize the various regulatory bodies and organizations with oversight or
More informationCore Purpose the organization s reason for being and Core Values essential and enduring principles that guide the behavior of an organization.
STRATEGIC PLAN SNMMI s Timeless Core Ideology Core Ideology describes an organization s consistent identity that transcends all changes related to its relevant environment. Core ideology consists of two
More informationHospital and Other Healthcare Facilities
Hospital and Other Healthcare Facilities Council Progress Report December 2015 Judy Chong, RPh, BScPhm Manager, Hospital and Other Healthcare Facilities Agenda Background Drug Preparation Premises (DPPs)
More informationPHARMACY SERVICES / MEDICATION USE
25.01.02 Supervision of Pharmacy Activities. In order to provide patient safety, drugs and biologicals must be controlled and distributed in accordance with applicable standards of practice consistent
More informationQUALITY MANAGEMENT PROGRAM FOR HUMAN RESEARCH SUBJECT UNIVERSITY OF CINCINNATI
Effective January 27, 1992 Modified: August 10, 1993; March 8, 1994; August 11, 1994; July 18, 1995; September 23, 1997, November 14, 2001, May 19, 2004, June 17, 2006 and (November 8, 2006) I. Purpose
More informationMEDICATION MANAGEMENT IN NUCLEAR MEDICINE
MEDICATION MANAGEMENT IN NUCLEAR MEDICINE OBJECTIVES At the conclusion of this program, the nuclear medicine technologist will be able to do the following: Describe the purpose of Conditions of Participation
More informationUniversity of Maryland Baltimore. Radiation Safety Procedure
University of Maryland Baltimore Procedure Number: 4.4 Radiation Safety Procedure Title: Radiation Safety During Therapeutic Radiopharmaceutical Procedures Revision Number: 0 Technical Review and Approval:
More informationHEALTH P H Y S I C S SOCIETY
HEALTH P H Y S I C S SOCIETY Specialists in Radiation Safety March 29, 2017 Cindy Bladey Office of Administration U.S. Nuclear Regulatory Commission Mail Stop: OWFN 12 H08, Washington, DC20555 0001. Eric
More informationRegulatory Issues Licensure by State Department of Nuclear Safety/Homeland Security or NRC Current License required or a "Timely Filed Notice"
After reviewing this tutorial, participants should Know the basics of licensure by the NRC and State regulatory agencies Be able to state the difference between agreement states and non-agreement states
More informationMobile Positron Emission Tomography
Mobile Positron Emission Tomography PURPOSE This procedure provides general instructions for developing, maintaining, and documenting radiation protection procedures for preparation, calibration and administration
More informationMONITORING HEALTH CARE INDUSTRY REPRESENTATIVES EXPOSED TO IONIZING RADIATION
MONITORING HEALTH CARE INDUSTRY REPRESENTATIVES EXPOSED TO IONIZING RADIATION NVLAP Accredited Organization Position paper with data analysis from Chris Passmore, CHP and Mirela Kirr In this white paper,
More informationFifty Shades Of Gray A Medical Physicists Guide as RSO. Kevin Nelson, Ph.D, CHP Mayo Clinic Florida
Fifty Shades Of Gray A Medical Physicists Guide as RSO Kevin Nelson, Ph.D, CHP Mayo Clinic Florida nelson.kevin2@mayo.edu Objectives Review training and education requirements for a Radiation Safety Officer
More informationSterile Compounding: Highlights of the New Law
Patricia C. Kienle, RPh, MPA, FASHP Director, Accreditation and Medication Safety Cardinal Health Innovative Delivery Solutions Sterile Compounding: Highlights of the New Law 2 Please explain the difference
More informationYale University ALARA (AS LOW AS REASONABLY ACHIEVABLE) PROGRAM
Yale University ALARA (AS LOW AS REASONABLY ACHIEVABLE) PROGRAM 1. Management Commitment a. The goal of the ALARA program is to maintain ionizing radiation exposures to individuals and releases to the
More informationRADIOACTIVE MATERIALS REGULATORY GUIDE
RADIOACTIVE MATERIALS REGULATORY GUIDE ANNUAL AUDIT CHECKLIST FOR MEDICAL FACILITIES Radioactive Materials Unit 625 Robert Street North PO Box 64975 St. Paul, Minnesota 55164-0975 February 13, 2009 TABLE
More informationRadiation Control Chapter Use of Radionuclides in the Healing Arts
420-3-26-.07 Use of Radionuclides in the Healing Arts (1) Purpose and Scope. This rule establishes requirements and provisions for the production, preparation, compounding and use of radionuclides in the
More informationCHAPTER 29 PHARMACY TECHNICIANS
CHAPTER 29 PHARMACY TECHNICIANS 29.1 HOSPITAL PHARMACY TECHNICIANS 1. Proper Identification as Pharmacy Technician 2. Policy and procedures regulating duties of technician and scope of responsibility 3.
More informationLicensing and Registration of Radiation Sources
Licensing and Registration of Radiation Sources Presentation for an Ionizing Radiation Committee Round Table 244 on Radiation Safety Program Challenges for IHs May 26, 2016 American Industrial Hygiene
More informationNRC INSPECTION MANUAL
NRC INSPECTION MANUAL MSSA/RMSB INSPECTION PROCEDURE 87132 BRACHYTHERAPY PROGRAMS PROGRAM APPLICABILITY: 2800 87132-01 INSPECTION OBJECTIVES 01.01 To determine if licensed activities are being conducted
More informationRepublic of the Philippines Department of Science and Technology PHILIPPINE NUCLEAR RESEARCH INSTITUTE Don Mariano Marcos Avenue Diliman, Quezon City
Republic of the Philippines Department of Science and Technology PHILIPPINE NUCLEAR RESEARCH INSTITUTE Don Mariano Marcos Avenue Diliman, Quezon City LICENSES TO MANUFACTURE AND DISPENSE RADIOPHARMACEUTICALS
More informationAGENDA FOR CHANGE NHS JOB EVALUATION SCHEME JOB DESCRIPTION
AGENDA FOR CHANGE NHS JOB EVALUATION SCHEME JOB DESCRIPTION 1. JOB IDENTIFICATION Job Title: Reports to: Department, Ward or Section: Radiopharmacy Production Manager (Nuclear Medicine) Support Division,
More informationLocal Government Records Control Schedule
Local s Control Schedule 1. Page 58 of 116 PS4525-01 HR4750-01 EMERGENCY MEDICAL SERVICE TRAINING RECORDS HEALTH SERVICES APPOINTMENT RECORDS s relating to the training (including continuing education)
More informationNUCLEAR MEDICINE AND MOLECULAR IMAGING H. Lee Moffitt Cancer Center and Research Institute
NUCLEAR MEDICINE AND MOLECULAR IMAGING H. Lee Moffitt Cancer Center and Research Institute Rotation Director: Claudia Berman, M.D. General Goals: On this rotation, the resident will learn dynamic and static
More informationRadiation Licensure and Management (RS100) Course
Intro/Opening Welcome to the Radiation Licensure and Management course. This training is designed and required for anyone who is requesting a Radiation License at UAB. The intent of this course is to inform
More informationBrachytherapy-Radiopharmaceutical Therapy Quality Management Program. Rev Date: Feb
Section I outlines definitions, reporting, auditing and general requirements of the QMP program while Section II describes the QMP implementation for each therapeutic modality. Recommendations are expressed
More informationSan Antonio Uniformed Services Health Education Consortium San Antonio, Texas. Nuclear Medicine Fellowship Supervision Policies
San Antonio Uniformed Services Health Education Consortium San Antonio, Texas Nuclear Medicine Fellowship Nuclear Medicine Fellowship Supervision Policies I. Applicability The SAUSHEC Command Council [Commanders
More informationFingerprinting and Criminal History Records Check Requirements for Unescorted Access to Certain Radioactive Material
Fingerprinting and Criminal History Records Check Requirements for Unescorted Access to Certain Radioactive Material I BACKGROUND Section 274 of the Atomic Energy Act (AEA) of 1954, as amended, provides
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationUS Compounding 2515 College Ave Conway, AR (800)
PCAB Compounding Accreditation Accreditation Summary US Compounding 2515 College Ave Conway, AR 72034 (800) 718 3588 www.uscompounding.com Date of Last In-Pharmacy Survey: June 2008 Next Scheduled In-Pharmacy
More informationLESSON ASSIGNMENT. Professional References in Pharmacy.
LESSON ASSIGNMENT LESSON 1 Professional References in Pharmacy. TEXT ASSIGNMENT Paragraphs 1-1 through 1-8. LESSON OBJECTIVES 1-1. Given a description of a reference used in pharmacy and a list of pharmacy
More informationProcedure. AREAS OF RESPONSIBILITY Nuclear medicine technologists Attending radiology physicians Radiology resident physicians
Title: Radiology Identification and Instruction of Breast-Feeding Patients DESCRIPTION/OVERVIEW To establish procedures, in accordance with general radiation safety principles and New Mexico Environment
More informationNational Council on Radiation Protection and Measurements Homeland Security Recommendations Related to Nuclear and Radiological Terrorism
National Council on Radiation Protection and Measurements Homeland Security Recommendations Related to Nuclear and Radiological Terrorism DHS Standards Program Review August 29, 2006 Name - DA Schauer
More informationDepartment of Defense INSTRUCTION. Occupational Ionizing Radiation Protection Program
Department of Defense INSTRUCTION NUMBER 6055.08 December 15, 2009 Incorporating Change 1, November 17, 2017 USD(AT&L) SUBJECT: Occupational Ionizing Radiation Protection Program References: See Enclosure
More informationSubj: ACQUISITION, USE AND DISPOSAL OF CERTAIN NUCLEAR REGULATORY COMMISSION REGULATED RADIOACTIVE DEVICES AND SOURCE MATERIAL
DEPARTMENT OF THE NAVY OFFICE OF THE CHIEF OF NAVAL OPERATIONS 2000 NAVY PENTAGON WASHINGTON, DC 20350-2000 IN REPLY REFER TO OPNAVINST 6470.4 N45 OPNAV INSTRUCTION 6470.4 From: Chief of Naval Operations
More informationNuclear Pharmacy. Background
1 Nuclear Pharmacy Background Nuclear pharmacy was the first pharmacy specialty established by the Board of Pharmaceutical Specialties (BPS) in 1978. This specialty area is involved with the preparation
More information2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question. Disclosures. Learning Objectives 3/16/2017
2017 ASHP Proposed Policies: To Approve or Not to Approve, That is the Question Nicole Allcock, PharmD, BCPS, FASHP Noelle RM Chapman, PharmD, BCPS, FASHP Joel Hennenfent, PharmD, MBA, BCPS, FASHP Jen
More informationDepartment of Defense INSTRUCTION
Department of Defense INSTRUCTION NUMBER 6055.8 March 31, 1989 SUBJECT: Occupational Radiation Protection Program Administrative Reissuance Incorporating Change 1, May 6, 1996 USD(A&T) References: (a)
More informationPET Accreditation Program Requirements
PET Accreditation Program Requirements REVISIONS... 2 REVISIONS... 2 OVERVIEW... 3 MEDICARE IMPROVEMENT F PATIENTS AND PROVIDERS ACT OF 2008 (MIPPA)... 3 MANDATY ACCREDITATION TIME REQUIREMENTS... 4 WITHDRAWN,
More informationRADIATION PROTECTION PROGRAM FOR USE OF RADIATION GENERATING MACHINES IN THE HEALING ARTS, RESEARCH AND EDUCATION
RADIATION PROTECTION PROGRAM FOR USE OF RADIATION GENERATING MACHINES IN THE HEALING ARTS, RESEARCH AND EDUCATION Radiation Safety Office 629 Wareham Parkway Criss I, Room 213 Omaha, NE 68178 Phone: 402-280-5570
More informationDOD INSTRUCTION DOD LOW-LEVEL RADIOACTIVE WASTE (LLRW) PROGRAM
DOD INSTRUCTION 4715.27 DOD LOW-LEVEL RADIOACTIVE WASTE (LLRW) PROGRAM Originating Component: Office of the Under Secretary of Defense for Acquisition, Technology, and Logistics Effective: July 7, 2017
More informationMINNESOTA DEPARTMENT OF HEALTH
MINNESOTA DEPARTMENT OF HEALTH REGULATORY GUIDE FOR GAS CHROMATOGRAPHS AND X-RAY FLUORESCENCE ANALYZERS Radioactive Materials Unit Minnesota Department of Health 625 Robert Street North P.O. Box 64975
More informationEffective dose to patients and staff when using a mobile PET/SPECT system
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 14, NUMBER 3, 2013 Effective dose to patients and staff when using a mobile PET/SPECT system Matthew T. Studenski a Department of Radiation Oncology,
More informationUSP <797> and <825> -- Current and Future Standards for Sterile Preparation and Compounding of Radiopharmaceuticals
USP and -- Current and Future Standards for Sterile Preparation and Compounding of Radiopharmaceuticals James A. Ponto, MS, RPh, BCNP University of Iowa Target Audience: Pharmacists ACPE#:
More informationUniversity of Maryland Baltimore. Radiation Safety Procedure
University of Maryland Baltimore Procedure Number: 1.1 Radiation Safety Procedure Title: Radiation Safety Program Organization and Administration Revision Number: 0 Technical Review and Approval: Radiation
More informationEffective Date: 6/15/77. Date Reviewed:
Classification: Radiology Policy Number: 668.027 Subject: ALARA Program for Radiation Exposure Contact Position: Radiology Director Effective Date: 6/15/77 Date Reviewed: Page: 1 of 5 Date Revised: 7/02,
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationNUCLEAR MEDICINE James A. Haley Veterans Administration Hospital
NUCLEAR MEDICINE James A. Haley Veterans Administration Hospital Rotation Director: Dwight Achong, M.D. General Goals: During this rotation, the resident will learn how to perform and interpret dynamic
More informationLEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS
LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS Joey Gouws MCC and Cluster: Food Control, Pharmaceutical Trade and Product Regulation NATIONAL DEPARTMENT OF HEALTH
More informationUniversity of Maryland Baltimore. Radiation Safety Procedure
University of Maryland Baltimore Radiation Safety Procedure Procedure Number: 4.1 Title: Quality Management Program Revision Number: 0 Technical Review and Approval: Radiation Safety Officer Date: Radiation
More informationMISSISSIPPI LEGISLATURE REGULAR SESSION 2013
MISSISSIPPI LEGISLATURE REGULAR SESSION 2013 By: Representative Formby To: Public Health and Human Services HOUSE BILL NO. 69 1 AN ACT TO AMEND SECTIONS 41-58-1, 41-58-3 AND 41-58-5, 2 MISSISSIPPI CODE
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationUnderstanding USP 797
Baxa Corporation Understanding USP 797 Technical Paper An Overview of USP General Chapter Pharmaceutical Compounding Sterile Preparations Mike Hurst, RPh, MBA 2004 Baxa Corporation Introduction USP
More informationNovember 18, Dear Ms. Vietti Cook:
Annette L. Vietti Cook Secretary US Nuclear Regulatory Commission Washington, DC 20555 0001 Attn: Rulemakings and Adjudications Staff Re: Medical Use of Byproduct Material Medical Event Definitions, Training
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Patricia M. D Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control May 30, 2015 Organization Health
More informationUNIVERSITY OF SOUTH ALABAMA RADIATION SAFETY PROCEDURES MANUAL
UNIVERSITY OF SOUTH ALABAMA RADIATION SAFETY PROCEDURES MANUAL The University of South Alabama was granted a radioactive materials license to possess and use radioactive material for purposes of research
More informationPractice Spotlight. Children's Hospital Central California Madera, California
Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW
More informationHUMAN USE RADIATION SAFETY MANUAL
February 2, 1999 (Revised February 27, 2001) DEPARTMENT OF ENVIRONMENTAL HEALTH AND SAFETY Office of Radiation Safety 852-5231 I. INTRODUCTION 1 II. CHARTER FOR THE UNIVERSITY RADIATION SAFETY 2 COMMITTEE
More informationGENERAL INFORMATION BROCHURE FOR ACCREDITATION OF MEDICAL IMAGING SERVICES
GENERAL INFORMATION BROCHURE FOR ACCREDITATION OF MEDICAL IMAGING SERVICES 2010 Page 1 Introduction to Accreditation Program for Medical Imaging Services Definition of Medical Imaging Services (MIS) Medical
More informationVAMC Radiation Safety Refresher Training March 2011
VAMC Radiation Safety Refresher Training March 2011 The University of Iowa Radiation Safety Program 1 Taking The Course and Receiving Credit Who Should Complete This Course? You should complete this course
More informationThe ACHC-PCAB Pharmacy Accreditation Program
CPE CREDIT 1.0 Current & Practical Compounding Information for the Pharmacist VOLUME 19 NUMBER 1 Grant funding provided by Perrigo Pharmaceuticals Goal: To provide information on the importance and procedures
More informationCOMPLIANCE WITH THIS PUBLICATION IS MANDATORY
BY ORDER OF THE COMMANDER MACDILL AIR FORCE BASE MACDILL AIR FORCE BASE INSTRUCTION 48-100 23 JANUARY 2015 Aerospace Medicine INSTALLATION RADIATION SAFETY PROGRAM COMPLIANCE WITH THIS PUBLICATION IS MANDATORY
More informationPCAB Compounding Accreditation Accreditation Summary
PCAB Compounding Accreditation Accreditation Summary McGuff Compounding Pharmacy Services, Inc Santa Ana, California compounding pharmacy 2921 W. MacArthur Blvd., Ste.142 Santa Ana, CA 92704 Telephone:877-444-1133
More informationLook WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA
Look WHAT They ve Done to Us: Law Update 2014 October 2014 Greg Baran B.S. Pharm., M.A., FMPA Objectives: At the completion of this program, participants will be able to: 1. Recognize the changes made
More informationUSP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD
USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL ACTIVITY DESCRIPTION On June 1, 2008, The Revision Bulletin to USP Chapter 797, Pharmaceutical
More informationJob Series Matrix. Effective/Revision Date: 04/01/2015. Job Purpose Job Purpose Job Purpose Job Purpose Job Purpose Job Purpose
Job Family: Health and Safety Job Series: Health Physicist Job Series Summary: Perform technical work in health physics discipline to ensure the ionizing radiation exposure to the university and laboratory's
More informationQualifications for University Radiation Safety Officer
Standards of Qualification and Practice (SQ/P) Qualifications for University Radiation Safety Officer RSO Section American Academy of Health Physics and Radiation Safety Operations Section of the Health
More informationRadiologic technologists take x rays and administer nonradioactive materials into patients bloodstreams for diagnostic purposes.
http://www.bls.gov/oco/ocos105.htm Radiologic Technologists and Technicians Nature of the Work Training, Other Qualifications, and Advancement Employment Job Outlook Projections Data Earnings OES Data
More informationUNITED STATES SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS. Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak
UNITED STATES SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, AND PENSIONS Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak Thursday, November 15, 2012 10:00 a.m. 106 Dirksen Senate Office
More informationAPPLICATION FOR RENEWAL OF A RADIOACTIVE MATERIAL LICENSE AUTHORIZING THE USE OFINDUSTRIAL RADIOGRAPHY
Virginia Department of Health Radioactive Materials Program (804) 864-8150 APPLICATION F RENEWAL OF A RADIOACTIVE MATERIAL LICENSE AUTHIZING THE USE OFINDUSTRIAL RADIOGRAPHY The Virginia Department of
More informationCompetency Profile. Nuclear Medicine Technology
Competency Profile Entry-to-Practice competencies for the professions of the Alberta College of Medical Diagnostic and Therapeutic Technologists (ACMDTT) Nuclear Medicine Technology Under the Health Professions
More informationWalter L. Robinson & Associates Presents..
Walter L. Robinson & Associates Presents.. Copyright, 2006 Walter L. Robinson & Associates Note This presentation is intended for annual in-services or initial radiation safety orientations What Every
More informationCEOCFO Magazine. Andy Reeves, RPh Chief Executive Officer OptiMed Specialty Pharmacy
CEOCFO Magazine ceocfointerviews.com All rights reserved! Issue: October 30, 2017 Q&A with Andy Reeves, RPh, CEO of OptiMed Specialty Pharmacy, a National Specialty and Infusion Pharmacy dedicated to Managing
More informationSchool of Pharmacy. Dual Degree. Courses Pharmacy Practice Courses. Programs Doctor of Philosophy (PhD) Doctor of Pharmacy (PharmD)
School of Pharmacy 1 School of Pharmacy Website (http://www.northeastern.edu/bouve/pharmacy) John R. Reynolds, PharmD Professor and Dean Pharmaceutical Sciences 140 The Fenway 617.373.3406 617.373.8886
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationRADIOACTIVE MATERIALS REGULATORY GUIDE DIAGNOSTIC AND THERAPEUTIC MEDICAL PROCEDURES
RADIOACTIVE MATERIALS REGULATORY GUIDE DIAGNOSTIC AND THERAPEUTIC MEDICAL PROCEDURES Radioactive Materials Unit 625 Robert Street North P.O. Box 64975 St. Paul, MN 55164-0975 July 2007 TABLE OF CONTENTS
More informationDoing Business As name (if applicable): 2. Mailing Address: (Street Address/City/State/Zip) 3. Physical Location: (Street Address/City/State/Zip)
ZZ113-120 REGISTRATION APPLICATION FOR USERS OF RADIATION MACHINES HEALING ARTS, DENTAL, VETERINARY MEDICINE AND MEDICAL ACADEMIC FACILITIES TEXAS DEPARTMENT OF STATE HEALTH SERVICES (DSHS) RADIATION SAFETY
More informationAllied Health Department. Radiation Protection Program (RPP) Policies & Procedures
Allied Health Department Radiation Protection Program (RPP) Policies & Procedures REVISION: 12/12/2017 Allied Health- Radiologic Technology Kevin D. Yow, MHA., R.T. (R), Radiation Safety Officer (619)
More informationTHE UNIVERSITY OF AKRON
THE UNIVERSITY OF AKRON Radiation-Generating Equipment Quality Assurance Program INDEX I. Design of the Radiation-Generating Equipment Quality Assurance (QA) Program..... 1 A. Purpose of the QA Safety
More informationNuclear Fuel Cycle Technologies: Current Challenges and Future Plans Andrew Griffith U.S. Department of Energy, Washington, DC USA
Nuclear Fuel Cycle Technologies: Current Challenges and Future Plans - 12558 Andrew Griffith U.S. Department of Energy, Washington, DC USA ABSTRACT The mission of the Office of Nuclear Energy s Fuel Cycle
More informationRadiation Safety Manual
OFFICE OF RESEARCH Radiation Safety Manual RADIATION SAFETY OFFICE 1 UNIVERSITY OF NEW MEXICO MSC 08-4560 ALBUQUERQUE, NM 87131 (505) 272-4607 (505) 925-0745 The University of New Mexico Health Sciences
More informationDOE N /29/95 Expires: [1 year after initiation]
DOE N 441.1 SUBJECT: RADIOLOGICAL PROTECTION FOR DOE ACTIVITIES 9/29/95 Expires: [1 year after initiation] The Department of Energy (DOE) undertook an initiative to reduce the burden of unnecessary, repetitive,
More informationNUCLEAR MEDICINE PRACTITIONER COMPETENCIES
NUCLEAR MEDICINE PRACTITIONER COMPETENCIES INTRODUCTION The Society of Nuclear Medicine Technologist Section adopted the proposal for the development of a middle level practice provider, Nuclear Medicine
More informationNuclear Medicine Technologist Scope of Practice and Performance Standards
Nuclear Medicine Technologist Scope of Practice and Performance Standards Prepared by: Society of Nuclear Medicine and Molecular Imaging Technologist Section Approved: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationLEARNING OBJECTIVES Patient Care
LEARNING OBJECTIVES Patient Care 1. Obtain pertinent medical histories by review of patient medical records. 2. Screen patients for suitability for stress testing, including the performance of focused
More informationRadiotherapy Licence Application Form
Radiotherapy Licence Application Form Section A Applicant A1 Type of request Construction Renewal Operating to commission Decommissioning Routine operation (amendment) Current licence # A2 Language of
More informationComponents of Preparedness
Components of Preparedness Components of preparedness statements are published by the NMTCB to assist students, program directors, and item writers. Each task is keyed to the 2013 Task published by the
More information